GlassScriptPhysician profile
Hannah E Kertz
NPI 1043716830
$817.64
in general payments reported to CMS, 2019-2025
12 companies · $67.82 in 2025
The $67.82 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.35 · 2021: $343 · 2022: $73.52 · 2023: $198 · 2024: $118 · 2025: $67.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $346.21 | 2021-2022 | |
| Organon LLC | $153.16 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $76.41 | 2022-2024 | Slynd |
| Lsi Solutions INC | $58.37 | 2023 | Fornisee |
| Astellas Pharma US INC | $43.27 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $27.85 | 2023 | Cologuard Collection Kit |
| Myriad Women'S Health, INC. | $22.39 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $22.36 | 2024 | Gemtesa |
| Mayne Pharma Commercial LLC | $19.06 | 2025 | |
| Kci USA, INC. | $17.82 | 2021 | |
| Abbvie INC. | $17.35 | 2020 | |
| Smith+Nephew, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Kertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.